A detailed history of Frank, Rimerman Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 16,215 shares of VTRS stock, worth $210,795. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,215
Previous 13,076 24.01%
Holding current value
$210,795
Previous $138,000 36.23%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.32 - $12.13 $32,394 - $38,076
3,139 Added 24.01%
16,215 $188,000
Q2 2024

Aug 13, 2024

BUY
$10.05 - $12.02 $130,760 - $156,392
13,011 Added 20016.92%
13,076 $138,000
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $570 - $705
65 New
65 $704,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.